Clinical Trial Update: MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation [NA]

View source ↗

Summary

A clinical trial update examining microRNA expression in kidney transplant patients managed with everolimus-based versus tacrolimus-based regimens.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chulalongkorn University | Conditions: microRNA Profiles | NA | Status: UNKNOWN